Accentia Biopharmace (ABPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2012 | 09-2011 | 09-2010 | 09-2009 | 09-2008 | |
| Sales | 4,054 | 3,956 | 5,356 | 10,556 | 14,272 |
| Cost of Goods | 2,770 | 2,490 | 2,901 | 7,838 | 8,594 |
| Gross Profit | 1,285 | 1,466 | 2,455 | 2,718 | 5,678 |
| Operating Expenses | 13,592 | 23,128 | 6,960 | 11,909 | 36,828 |
| Operating Income | -11,538 | -21,172 | -3,604 | -8,353 | -30,556 |
| Interest Expense | 7,908 | 8,093 | 16,660 | 8,437 | 28,057 |
| Other Income | 7,019 | 13,438 | -27,944 | 11,532 | -2,178 |
| Pre-tax Income | -12,428 | -15,827 | -48,207 | -5,258 | -60,792 |
| Income Tax | N/A | -5 | 3 | 5 | N/A |
| Net Income Continuous | -12,428 | -15,823 | -48,211 | -5,263 | -60,792 |
| Net Income Discontinuous | 3,240 | 179 | N/A | N/A | N/A |
| Minority Interests | -4,865 | -4,100 | -412 | N/A | N/A |
| Net Income | $-4,323 | $-11,553 | $-47,799 | $-5,263 | $-60,792 |
| EPS Basic Total Ops | -0.05 | -0.17 | -0.86 | -0.14 | -1.39 |
| EPS Basic Continuous Ops | -0.15 | -0.23 | -0.82 | -0.12 | -1.20 |
| EPS Basic Discontinuous Ops | 0.40 | 0.00 | -0.01 | 0.03 | -0.13 |
| EPS Diluted Total Ops | -0.05 | -0.17 | -0.86 | -0.14 | -1.39 |
| EPS Diluted Continuous Ops | -0.15 | -0.23 | -0.82 | -0.12 | -1.20 |
| EPS Diluted Discontinuous Ops | 0.40 | 0.00 | -0.01 | 0.03 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.17 | -0.86 | -0.10 | -1.43 |
| EBITDA(a) | $-11,288 | $-20,610 | $-2,617 | $-6,352 | $-19,314 |